ANI Pharmaceuticals Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -2,199.5% | – | – | – | – | – | – | -21.6% | +59.1% | +43.5% | +70.2% | -32.0% | -66.5% | -78.2% | -1,039.3% | – | -46.2% | +189.3% | |
| – | -34.9% | +35.0% | -10.0% | -16.7% | +0.9% | +9.7% | -1.0% | +16.7% | -23.7% | -52.0% | +218.2% | +22.4% | -11.8% | +74.7% | +328.7% | +249.4% | +77.9% | +223.8% | +25.0% | +20.8% | +32.2% | +0.1% | +5.9% | +26.2% | +0.2% | +13.3% | +35.0% | |
| – | – | – | – | +0.0% | +972.2% | +196.7% | +61,293.0% | – | – | – | +13.8% | -20.9% | +18.6% | -38.4% | +513.8% | -23.1% | +12.6% | +57.3% | +0.4% | +11.4% | +35.9% | +40.3% | -18.9% | +39.2% | +41.5% | +42.1% | +29.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +248.6% | -99.0% | -18,163.8% | – | +90.2% | +174.7% | -67.7% | -27.1% | +58.3% | -195.6% | – | – | – | – | |
| – | – | – | +416.8% | -144.2% | – | +493.8% | -83.2% | -6,045.3% | – | -91.6% | -346.9% | – | -34.6% | -316.1% | – | – | – | – | – | – | -344.3% | – | – | – | – | -145.0% | – | |
| – | -96.6% | +924.8% | +100.6% | -55.0% | -77.3% | +1,064.2% | -34.7% | -41.8% | -25.0% | +2,112.6% | -74.5% | -61.7% | +1,034.8% | -15.1% | -68.7% | +18,619.4% | -8.6% | +356.1% | -27.6% | -89.9% | +152.5% | +148.0% | -65.4% | -30.4% | +12.5% | -8.4% | +102.4% | |
| – | -96.6% | +924.8% | +100.6% | -55.0% | -77.3% | +182,662.2% | – | -31.6% | -326.8% | – | -74.7% | -102.1% | +1,092.6% | -14.0% | – | -276.4% | -8.6% | +371.4% | -29.9% | -74.6% | +0.6% | +148.0% | +54.4% | -85.1% | +17.6% | +2,086.4% | -91.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +2,920.0% | -89.2% | -69.3% | +755.3% | +0.0% | +0.0% | -28.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | +65,705.5% | – | -100.3% | +2,220.4% | -90.1% | +154.4% | +56.4% | +47.7% | -41.6% | +120.1% | +154.6% | +119.8% | +11.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -45.7% | -100.4% | – | -140.0% | +319.7% | -99.6% | – | -103.0% | +0.0% | – | -102.9% | |
| – | -0.8% | -86.1% | +546.4% | +15.3% | +123.2% | +91.0% | -98.9% | +3,633.8% | +150.5% | -98.3% | +10,441.7% | +43.9% | +39.6% | -94.9% | -206.3% | – | -99.4% | -168.4% | – | -138.4% | – | -215.1% | – | -102.6% | – | +292.9% | -103.8% | |
| – | +123.1% | -209.4% | – | -79.8% | +1,014.7% | -287.4% | – | – | +8.9% | -148.6% | – | -54.2% | +129.8% | -217.6% | – | +1,323.6% | -109.1% | – | – | +214.0% | +62.7% | -381.9% | – | -156.3% | – | -145.4% | – | |
| – | – | – | – | – | – | – | – | – | – | -2,378.1% | – | – | – | – | – | – | – | – | – | – | -67.8% | -393.4% | – | – | – | -53.1% | +220.6% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.